Table 2. Demographic information and preoperational data of PHLF patients.
Variables | 40 PHLF patients | ||
---|---|---|---|
Age: median (range) | 59.5 (39-74) | ||
Gender | |||
Male | 32 (80.00%) | ||
Female | 8 (20.00%) | ||
Hepatitis B (HbsAg+) | 25 (62.50%) | ||
HBV-DNA<1000IU/ml | 14 (35.00%) | ||
HBV-DNA>1000IU/ml | 11 (27.50%) | ||
Liver functional status | |||
Child-Pugh class A | 26 (65.00%) | ||
Child-Pugh class B | 14 (35.00%) | ||
Liver function tests | |||
ALT (U/L) | 72.25 (10-667) | ||
TBil (μmol/L) | 31.74 (7.7-154.6) | ||
ALB (g/L) | 37.18 (25-46) | ||
PT (s) | 13.08 (10.5-17.3) | ||
Cirrhosis | 25 (62.50%) | ||
Tumor nodules | |||
N=1 | 30 (75.00%) | ||
N≥2 | 10 (25.00%) | ||
Operation time (min) | 295.5 (90-575) | ||
Type of Surgery | PHLF cases | Total cases | Incidence of PHLF |
Simple removal of tumor | 9 | 522 | 1.72% |
Single segment resection | 5 | 187 | 2.67% |
Multiple segment resection | 13 | 767 | 1.69% |
Hemihepatectomy | 13 | 207 | 6,28% |
Other parameters | |||
Pringle's maneuver | 21(52.50%) | ||
Ischemic duration (min) | 24.90 (11-57) | ||
Blood loss (ml) | 1110.00 (100-8000) | ||
Patients transfused (n) | 30(75.00%) | ||
RBC (unit) | 6.23 (2-30) | ||
Serum (ml) | 865.47 (300-2800) |
Numbers were shown as median (range). HBV: Hepatitis B Virus, RBC: Red Blood Cell.